Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Association between renin-angiotensin-aldosterone system blockade and future osteoporotic fracture risk in hypertensive population: A population-based cohort study in Taiwan.

Chen CI, Yeh JS, Tsao NW, Lin FY, Shih CM, Chiang KH, Kao YT, Fang YA, Tsai LW, Liu WC, Nakagami H, Morishita R, Kuo YJ, Huang CY.

Medicine (Baltimore). 2017 Nov;96(46):e8331. doi: 10.1097/MD.0000000000008331.

3.

Pharmacological treatment of osteoporosis in the oldest old.

Vandenbroucke A, Luyten FP, Flamaing J, Gielen E.

Clin Interv Aging. 2017 Jul 6;12:1065-1077. doi: 10.2147/CIA.S131023. eCollection 2017. Review.

4.

Declining Rates of Hip Fracture in End-Stage Renal Disease: Analysis From the 2003-2011 Nationwide Inpatient Sample.

Kim SM, Liu S, Long J, Montez-Rath ME, Leonard MB, Chertow GM.

J Bone Miner Res. 2017 Nov;32(11):2297-2303. doi: 10.1002/jbmr.3201. Epub 2017 Sep 11.

PMID:
28639740
5.

Gender Disparities in Osteoporosis.

Alswat KA.

J Clin Med Res. 2017 May;9(5):382-387. doi: 10.14740/jocmr2970w. Epub 2017 Apr 1. Review.

6.

Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis.

Hawley S, Leal J, Delmestri A, Prieto-Alhambra D, Arden NK, Cooper C, Javaid MK, Judge A; REFReSH Study Group.

J Bone Miner Res. 2016 Nov;31(11):2008-2015. doi: 10.1002/jbmr.2882. Epub 2016 Jul 4.

7.

Understanding effects in reviews of implementation interventions using the Theoretical Domains Framework.

Little EA, Presseau J, Eccles MP.

Implement Sci. 2015 Jun 17;10:90. doi: 10.1186/s13012-015-0280-7.

8.

Subgroup variations in bone mineral density response to zoledronic acid after hip fracture.

Magaziner JS, Orwig DL, Lyles KW, Nordsletten L, Boonen S, Adachi JD, Recknor C, Colón-Emeric CS, Mesenbrink P, Bucci-Rechtweg C, Su G, Johnson R, Pieper CF.

J Bone Miner Res. 2014 Dec;29(12):2545-51. doi: 10.1002/jbmr.2283.

9.

Utility of heel dual-energy X-ray absorptiometry in diagnosing osteoporosis.

Chou SH, Hwang J, Ma SL, Vokes T.

J Clin Densitom. 2014 Jan-Mar;17(1):16-24. doi: 10.1016/j.jocd.2013.09.006. Epub 2013 Oct 19.

10.

Clinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: evidence and opinions.

Ruza I, Mirfakhraee S, Orwoll E, Gruntmanis U.

Ther Adv Musculoskelet Dis. 2013 Aug;5(4):182-98. doi: 10.1177/1759720X13485829.

11.

Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia® (denosumab) for the treatment of postmenopausal osteoporosis.

Xue F, Ma H, Stehman-Breen C, Haller C, Katz L, Wagman RB, Critchlow CW; Denosumab Global Safety Assessment Team.

Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1107-14. doi: 10.1002/pds.3477. Epub 2013 Jul 15.

12.

An opportunity for improving osteoporosis treatment in home health care.

Switzer JA, Rolnick SJ, Jackson JM, Schneider NK, Dutkowski JE, Edgett DR.

Geriatr Orthop Surg Rehabil. 2010 Nov;1(2):46-51. doi: 10.1177/2151458510386950.

13.

Denosumab in postmenopausal osteoporosis: what the clinician needs to know.

Lewiecki EM.

Ther Adv Musculoskelet Dis. 2009 Feb;1(1):13-26. doi: 10.1177/1759720X09343221.

14.

Effect of Medicare reimbursement reduction for imaging services on osteoporosis screening rates.

McAdam-Marx C, Unni S, Ye X, Nelson S, Nickman NA.

J Am Geriatr Soc. 2012 Mar;60(3):511-6. doi: 10.1111/j.1532-5415.2011.03837.x. Epub 2012 Feb 13.

15.

Improving osteoporosis care in high-risk home health patients through a high-intensity intervention.

Outman RC, Curtis JR, Locher JL, Allison JJ, Saag KG, Kilgore ML.

Contemp Clin Trials. 2012 Jan;33(1):206-12. doi: 10.1016/j.cct.2011.09.020. Epub 2011 Oct 8.

16.

What Do Israeli Osteoporotic Men Know and Do about Their Disease?

Edelstein OE.

J Osteoporos. 2011;2011:719862. doi: 10.4061/2011/719862. Epub 2011 Jun 14.

17.
18.

Community based intervention to optimize osteoporosis management: randomized controlled trial.

Ciaschini PM, Straus SE, Dolovich LR, Goeree RA, Leung KM, Woods CR, Zimmerman GM, Majumdar SR, Spadafora S, Fera LA, Lee HN.

BMC Geriatr. 2010 Aug 27;10:60. doi: 10.1186/1471-2318-10-60.

19.

Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study.

Fraser LA, Ioannidis G, Adachi JD, Pickard L, Kaiser SM, Prior J, Brown JP, Hanley DA, Olszynski WP, Anastassiades T, Jamal S, Josse R, Goltzman D, Papaioannou A; CaMos Research Group.

Osteoporos Int. 2011 Mar;22(3):789-96. doi: 10.1007/s00198-010-1359-2. Epub 2010 Aug 4.

20.

Supplemental Content

Support Center